Myeloma Rounds Philadelphia

Format

Live, In-Person Event

*Pre-registration required. 

Live interactive continuing medical education activity for healthcare professionals in Philadelphia, New Jersey, Delaware, and surrounding areas to discuss myeloma updates and challenges in treatment.

Target Audience

This activity is intended for hematologists-oncologists, medical oncologists, physician associates, nurse practitioners, nurses and pharmacists involved in the care of patients with myeloma. 

Agenda

6:30 PM – Dinner and Networking

7:00 PM – Welcome and Overview of Program
Edward A. Stadtmauer, MD

7:05 PM –  Overview of LLS Resources
Ruby Nava-Ramos, MPH

7:15 PM – Case Presentation and Discussion on Unusual Complications with Bispecific Treatments, CNS Toxoplasmosis, CMV Activation, PML
Anil K. Rengan, MD and Jessica Rais, MD

7:45 PM– Case Presentation and Discussion on Treatment of Smoldering Myeloma
Adam Waxman, MD, MS and Daria Madeeva, MD

8:15 PM – Case Presentation and Discussion on Newly Diagnosed Myeloma: How, When, and If We Should Consolidate with Autologous Stem Cell Transplant
Adam Binder, MD and Tara Rakiewicz, MD

8:45 PM – Discussion and Wrap-up
All Faculty

9:00 PM – Conclusion
Edward A. Stadtmauer, MD

Educational Objectives

At the conclusion of this activity, participants will be better able to:

• Describe the latest developments in myeloma, including current and emerging treatments
• Engage patients and caregivers in clinical trials discussions on newly approved and emerging therapies for myeloma, including combination therapies, CAR T-cell therapy and bispecific antibodies
• Explain disparities and challenges in diagnosis and treatment of myeloma
• Apply evidence-based treatment strategies for optimal patient care
• Identify patient education and support resources 

Advisory Group

Edward A. Stadtmauer, MD (Chair) 
University of Pennsylvania
Abramson Cancer Center 
Philadelphia, PA

Adam Binder, MD 
Thomas Jefferson University Hospital 
Philadelphia, PA

Tulin Budak-Alpdogan, MD 
Cooper University Health Care 
Camden, NJ

Oxana Megherea, PharmD, BCOP
University of Pennsylvania
Abramson Cancer Center
Philadelphia, PA

Asya Varshavsky-Yanovsky, MD, PhD 
Temple University Health System 
Fox Chase Cancer Center 
Philadelphia, PA

Adam Waxman, MD, MS 
University of Pennsylvania 
Abramson Cancer Center 
Philadelphia, PA

Faculty

Edward A. Stadtmauer, MD (Chair) 
University of Pennsylvania 
Abramson Cancer Center 
Philadelphia, PA

Adam Binder, MD 
Thomas Jefferson University Hospital 
Philadelphia, PA

Daria Madeeva, MD
University of Pennsylvania 
Abramson Cancer Center 
Philadelphia, PA

Ruby Nava-Ramos, MPH
The Leukemia & Lymphoma Society
Washington, DC

Jessica Rais, MD
Cooper University Health Care 
Camden, NJ

Tara Rakiewicz, MD
Thomas Jefferson University Hospital 
Philadelphia, PA

Anil K. Rengan, MD 
Cooper University Health Care 
Camden, NJ

Adam Waxman, MD, MS 
University of Pennsylvania 
Abramson Cancer Center 
Philadelphia, PA

Continuing Education Information

Accreditation, Credit and Support

In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute Inc and The Leukemia & Lymphoma Society.  Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
Medical Learning Institute Inc (MLI) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™.  

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participation information will be shared through the ACCME's Program and Activity Reporting System (PARS).

For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your ABIM ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit.

Physician Associate 

Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Nursing Continuing Professional Development Contact Hours
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 2.0 continuing education contact hours through the California Board of Registered Nursing.

Pharmacy
Medical Learning Institute Inc designates this application-based continuing education activity for 2.0 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA0007322-9999-25-009-L01-P

For Pharmacists, Medical Learning Institute Inc will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/

Interprofessional Continuing Education Credit

This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Method of Participation
There are no fees for participating in or receiving credits for this CE activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

In order to receive credit, learners must participate in the entire CE activity, complete the activity pre/post-assessment and evaluation form, and return it to staff at the end of the program. A certificate of completion will be emailed within 30 days of receipt. If you have questions regarding the receipt of your certificate, please contact us via email at ndane@mlieducation.org.

Providers
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute Inc, in collaboration with the Association of Cancer Care Centers™ (ACCC).

Supporter
Supported by educational grants from Adaptive Biotechnologies Corporation and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

CLICK HERE TO REGISTER

For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: profeducation@LLS.org.